Document is current
Any future updates will be listed below
-
Authors
König, Jochem
Stauch, Anette
Engel, Corinna
Urschitz, Michael S.
Franz, Axel R.
,
Poets, Christian F.
Hummler, Helmut
Niemarkt, Hendrik J.
Bassler, Dirk
Maiwald, Christian A.
Bergmann, Iris
Weiss, Monika
Eichhorn, Andreas
Raubuch, Michael
Roth, Michael
Schuler, Birgit
Rötsch, Kai
Bai, Ruimiao
Fiedler, Andreas
Kapp, Sonja
Völkl, Thomas M. K.
Horsinka, Sibylle C.
Hammond, Edmondo N. L.
von Buch, Christoph
Körner, Hans Thorsten
Tröger, Birte
Rüdiger, Mario
Seipolt, Barbara
Mense, Lars
Hoehn, Thomas
Lohmeier, Klaus
Bittrich, Hans-Jörg
Roefke, Kathrin
Niethammer, Klaus
Brenner, Britta
Raecke, Olaf
Fuchs, Hans
Klotz, Daniel
Koluch, Anna
Idel, Sandra
Lübking, Laura
Bohnhorst, Bettina
Peter, Corinna
Jacobi, Christoph
Gille, Christian
Beedgen, Bernd
Heinzmann, Tina
Meyer, Sascha
Kühr, Joachim
Holz, Sandra
Welcker, Silvia
Thome, Ulrich H.
Ackermann, Benjamin W.
Gebauer, Corinna
Flemmer, Andreas W.
Herber-Jonat, Susanne
Kley, Adelheid
Krüger, Marcus
Reber, Daniela
Krüger, Marcus
Brickmann, Christian
Ackermann, Kilian
Sandkötter, Julia
Masjosthusmann, Katja
Schroth, Michael
Grillhösl, Christian
Kittel, Jochen
Michel, Holger
Schneider, Hans-Christoph
Mayer, Anja
Lode, Hans-Martin
Lorenz, Daniel
Bosk, Axel T.
Gausepohl, Hans-Jürgen
Lindner, Torben
Vochem, Matthias
Strahleck, Thomas
Neuberger, Patrick
Maiwald, Christian A.
Arand, Jörg
Ehrhardt, Harald
Mendler, Marc R.
Essers, Jochen
Bender, Christian
Beckmann, Jessica
Mammodova, Narmina
Rauch, Ralf
Bernbeck, Ulrich
Niemarkt, Hendrik J.
Mohns, Thilo
Mulder, Estelle E. M.
van Straaten, Henrica L. M.
Hütten, Matthias
van Westering-Kroon, Elke
Nair, Vrinda
-
Funding
Funding for this research was provided by:
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 13 July 2024
Accepted: 5 November 2024
First Online: 12 November 2024
Declarations
:
: The FiO<sub>2</sub>-C trial was performed in accordance with the Declaration of Helsinki and the guidelines of Good Clinical Practice. Parents or guardians of the participating infants were informed about the trial and their written informed consent was required before inclusion.The study was approved by all ethics committees of the participating institutions; it was also approved by the German authority BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) as it was conducted as pharmaceutical trial in Germany with the investigational medicinal product ‘oxygen’. The study was also a medicinal product study within the intended use of studied devices.<i>Ethics:</i>• Ethics Committee of Northwest Woman and Children Hospital, Xi’an, China; Document No. 21-041—18th Oct 2021• Ethics Committee at the University Hospital Tübingen, reference no. 170/2018AMG1, approved; Adviescommissie Onderzoek Máxima Medisch Centrum, Veldhoven, the Netherlands METC-No. w18.061, CCMO-No.: N165766.015.l8—1 April 2019• West of Scotland Research Ethics Service, Paisley, UK; IRAS Project ID: 317261, REC-reference 22/WS/0143—22 November 2022, Health Research Authority approval IRAS Project ID: 317261—25 November 2022<i>Authority:</i>• BfArM, reference no. 4042695 approved conduct
: All authors and collaborators gave consent for publication. No personal data of participants is presented here.
: All contributors declare that they do not have competing interests.
